Sector strength · Hong Kong stocks
药品及生物科技
药品及生物科技 ranks 26 of 31 Hong Kong sectors and is rated weak: -10.91% over the past month, with 14% of its stocks up.
- Rank
- 26 / 31
- Strength
- Weak
- 1 day
- -0.91%
- 1 week
- -9.85%
- 1 month
- -10.91%
- Stocks up (1 month)
- 14%
- Stocks
- 88
- As of
- 2026-11-19
药品及生物科技 stocks
Largest 88 by market cap.
| Stock | Price | Day change | Market cap | Valuation |
|---|---|---|---|---|
| WuXi AppTec Co., Ltd. Class H 2359 | HK$188.30 | -0.84% | HK$608.20B | Fair |
| BeOne Medicines Ltd. 6160 | HK$242.60 | -0.90% | HK$342.24B | Low |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H 1276 | HK$45.30 | -2.75% | HK$304.91B | Below band |
| Hansoh Pharmaceutical Group Company Limited 3692 | HK$32.42 | -0.86% | HK$192.20B | Low |
| Wuxi Biologics (Cayman) Inc. 2269 | HK$43.84 | -1.79% | HK$188.94B | High |
| Innovent Biologics, Inc. 1801 | HK$85.45 | +2.34% | HK$151.89B | Low |
| JD Health International, Inc. 6618 | HK$32.42 | -7.00% | HK$131.66B | Fair |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H 6990 | HK$422.00 | -0.52% | HK$105.17B | Low |
| CSPC Pharmaceutical Group Limited 1093 | HK$8.30 | +3.94% | HK$99.23B | Low |
| Sino Biopharmaceutical Limited 1177 | HK$5.37 | -0.92% | HK$99.06B | Fair |
| Genscript Biotech Corporation 1548 | HK$30.16 | -2.20% | HK$96.69B | High |
| WuXi XDC Cayman, Inc. 2268 | HK$63.25 | -4.24% | HK$86.37B | Fair |
| Akeso, Inc. 9926 | HK$61.00 | +3.39% | HK$83.86B | Low |
| Asymchem Laboratories (Tianjin) Co., Ltd. Class H 6821 | HK$108.70 | -0.64% | HK$56.28B | Above band |
| Sinopharm Group Co., Ltd. Class H 1099 | HK$16.98 | +0.47% | HK$52.93B | Low |
| Pharmaron Beijing Co., Ltd. Class H 3759 | HK$26.44 | -1.64% | HK$51.70B | Fair |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class H 2196 | HK$15.11 | +0.00% | HK$43.23B | Below band |
| Shanghai Pharmaceuticals Holding Co. Ltd. Class H 2607 | HK$11.00 | +0.09% | HK$42.68B | Fair |
| InSilico Medicine Cayman TopCo 3696 | HK$33.46 | -3.35% | HK$36.88B | Fair |
| RemeGen Co. Ltd. Class H 9995 | HK$60.50 | -0.58% | HK$35.83B | Below band |
| 3SBio, Inc. 1530 | HK$13.19 | -0.83% | HK$34.89B | Below band |
| XtalPi Holdings Limited 2228 | HK$5.23 | -2.97% | HK$31.40B | Below band |
| Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H 2315 | HK$36.92 | -0.11% | HK$30.60B | Fair |
| Hangzhou Tigermed Consulting Co., Ltd. Class H 3347 | HK$33.34 | -0.71% | HK$30.17B | Low |
| China Resources Pharmaceutical Group Ltd. 3320 | HK$4.46 | -0.89% | HK$28.21B | Low |
| Simcere Pharmaceutical Group Limited 2096 | HK$10.47 | +0.48% | HK$26.96B | Low |
| Shanghai Henlius Biotech, Inc. Class H 2696 | HK$44.24 | +1.79% | HK$24.45B | Low |
| Zai Lab Ltd. 9688 | HK$17.35 | -2.91% | HK$22.36B | Above band |
| Livzon Pharmaceutical Group Inc Class H 1513 | HK$24.66 | -1.28% | HK$22.18B | Fair |
| Sunshine Lake Pharma Co., Ltd. Class H 6887 | HK$36.94 | +0.00% | HK$20.96B | Fair |
| Keymed Biosciences, Inc. 2162 | HK$67.50 | +0.45% | HK$20.33B | Low |
| InnoCare Pharma Ltd. 9969 | HK$10.53 | -2.68% | HK$19.92B | Low |
| United Laboratories International Holdings Ltd. 3933 | HK$7.15 | -0.90% | HK$16.68B | Low |
| JOINN Laboratories (China) Co., Ltd. Class H 6127 | HK$19.28 | -3.98% | HK$16.62B | Low |
| Fujian Haixi Pharmaceuticals Co., Ltd. Class H 2637 | HK$143.00 | -3.90% | HK$15.13B | Below band |
| Shanghai Junshi Biosciences Co., Ltd. Class H 1877 | HK$14.19 | +1.94% | HK$14.53B | Low |
| Consun Pharmaceutical Group Ltd. 1681 | HK$15.76 | -0.69% | HK$13.38B | Fair |
| Nanjing Leads Biolabs Co., Ltd. Class H 9887 | HK$30.08 | -1.96% | HK$12.60B | Above band |
| Vigonvita Life Sciences Co., Ltd. Class H 2630 | HK$76.20 | +0.26% | HK$12.14B | Fair |
| HBM Holdings Ltd. 2142 | HK$9.86 | -2.18% | HK$12.06B | Low |
| Metis TechBio Co., Ltd. Class H 7666 | HK$7.34 | +1.24% | HK$10.01B | Below band |
| Ascentage Pharma Group International 6855 | HK$24.62 | -0.81% | HK$9.76B | Fair |
| Everest Medicines Ltd. 1952 | HK$22.96 | -6.06% | HK$9.26B | Low |
| Duality Biotherapeutics, Inc. 9606 | HK$92.05 | +1.04% | HK$8.86B | Below band |
| CanSino Biologics, Inc. Class H 6185 | HK$22.00 | -2.57% | HK$8.65B | Fair |
| Mabwell (Shanghai) Bioscience Co., Ltd. Class H 2493 | HK$17.42 | -1.41% | HK$7.95B | Fair |
| Genfleet Therapeutics (Shanghai), Inc. Class H 2595 | HK$18.50 | -6.19% | HK$7.37B | Below band |
| Suzhou Ribo Life Science Co. Ltd. Class H 6938 | HK$40.00 | +1.73% | HK$7.34B | Below band |
| Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H 9989 | HK$3.92 | -1.63% | HK$5.90B | Fair |
| CARsgen Therapeutics Holdings Ltd. 2171 | HK$9.76 | -3.37% | HK$5.71B | Low |
| Xuanzhu Biopharmaceutical Co., Ltd. Class H 2575 | HK$7.50 | -2.60% | HK$4.95B | Below band |
| Ascletis Pharma, Inc. 1672 | HK$4.40 | +0.69% | HK$4.78B | Low |
| TenNor Therapeutics Suzhou Ltd. Class H 6872 | HK$74.50 | +7.50% | HK$3.59B | Below band |
| TransThera Sciences (Nanjing). Inc. 2617 | HK$6.74 | -3.02% | HK$2.96B | Below band |
| Alibaba Health Information Technology Ltd. 241 | HK$2.67 | -2.19% | — | — |
| IMPACT Therapeutics, Inc. Class H 07630 | HK$8.71 | +4.87% | — | — |
| CStone Pharmaceuticals 02616 | HK$6.00 | +1.87% | — | — |
| Luye Pharma Group Ltd. 02186 | HK$1.45 | -5.84% | — | — |
| HUTCHMED (China) Limited 13 | HK$21.48 | -1.01% | — | — |
| Sichuan Neautus Traditional Chinese Medicine Co., Ltd. Class H 02206 | HK$99.30 | +16.28% | — | — |
| 160 Health International Ltd. 02656 | HK$2.19 | -6.81% | — | — |
| Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H 2335 | HK$18.29 | -3.74% | — | — |
| PegBio Co., Ltd. Class H 02565 | HK$2.33 | -3.72% | — | — |
| Shanghai Bao Pharmaceuticals Co Ltd Class H 02659 | HK$10.42 | -6.13% | — | — |
| China Medical System Holdings Ltd. 867 | HK$9.54 | -0.47% | — | — |
| Jinxin Fertility Group Ltd. 01951 | HK$2.22 | -1.55% | — | — |
| Sihuan Pharmaceutical Holdings Group Ltd. 00460 | HK$0.7250 | -1.36% | — | — |
| Lepu Biopharma Co. Ltd. Class H 02157 | HK$2.52 | -1.94% | — | — |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H 874 | HK$12.40 | -1.20% | — | — |
| China Shineway Pharmaceutical Group Limited 02877 | HK$8.12 | +2.53% | — | — |
| Guangzhou Innogen Pharmaceutical Group Co Ltd Class H 02591 | HK$3.18 | -2.15% | — | — |
| SSY Group Limited 02005 | HK$2.54 | +0.79% | — | — |
| Abbisko Medicine Co., Ltd. 02256 | HK$6.17 | -2.06% | — | — |
| Grand Pharmaceutical Group Limited 512 | HK$4.17 | -2.91% | — | — |
| China Traditional Chinese Medicine Holdings Co. Ltd. 00570 | HK$1.11 | -1.77% | — | — |
| Laekna, Inc. 02105 | HK$5.99 | -3.86% | — | — |
| Alphamab Oncology 09966 | HK$5.33 | +0.09% | — | — |
| Jacobio Pharmaceuticals Group Co., Ltd. 01167 | HK$4.14 | +0.98% | — | — |
| LongBio Pharma (Suzhou) Co., Ltd. Class H 01779 | HK$48.10 | -6.33% | — | — |
| JW (Cayman) Therapeutics Co. Ltd. 02126 | HK$2.13 | -9.92% | — | — |
| CF PharmTech, Inc. Class H 02652 | HK$4.37 | -1.47% | — | — |
| Alebund Pharmaceuticals (Jiangsu) Limited Class H 09637 | HK$20.32 | +1.85% | — | — |
| Viva Biotech Holdings 01873 | HK$1.15 | -1.71% | — | — |
| Frontage Holdings Corp. 01521 | HK$2.07 | -0.72% | — | — |
| Shandong Xinhua Pharmaceutical Company Limited Class H 719 | HK$5.04 | -0.59% | — | — |
| CANbridge Pharmaceuticals Inc. 01228 | HK$1.66 | -2.65% | — | — |
| Jiangxi Institute of Biological Products Inc. Class H 06915 | HK$5.40 | +3.25% | — | — |
| JD Health International, Inc. 86618 | HK$29.68 | — | — | — |
All 32 Hong Kong sectors
How sector strength works
Each stock belongs to one sector: 申万 level-2 industries for China A-shares, Eastmoney industries for Hong Kong and industry groups for US stocks. A sector's strength blends its members' 1-day, 1-week and 1-month returns; breadth is the share of members up over the month. Sectors are ranked within their market and split into strong, neutral and weak thirds.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.